DiscoverHealth Equity in Focus
Health Equity in Focus
Claim Ownership

Health Equity in Focus

Author: Third World Network

Subscribed: 1Played: 10
Share

Description

Health Equity in Focus delves into the intricate dynamics of global health, examining how historical legacies continue to shape present-day realities in the Global South. Global health institutions, when failing to address deep-rooted issues, can perpetuate inequalities between North and South. Across various episodes, we explore issues like the implications of intellectual property to access to medicines, the use of policy space through TRIPS flexibilities, international regulatory standards, the intersection of biological diversity with health, and developments regarding these topics in international fora, through an equity perspective.

As a reflection of the Third World Network’s core mission, this podcast offers a fresh perspective on these matters. While our work often involves highly technical contributions, the subtext of our interventions advocates for a reimagined global order. This vision is one where development equips countries with the means to uplift their populations and foster a fairer, more equitable world. And that is the object of this conversation.

Find us on
Website
Twitter
Facebook
Instagram
LinkedIn

Credits
Production: Third World Network Berhad
Audio editing: Guilherme Conde
Original soundtrack (intro and outro): Daniel Gómez Rico
Artwork: Ames Sia

3 Episodes
Reverse
When Pfizer and other major corporations drafted the rules that became the WTO’s Agreement on Trade-Related Aspects of Intellectual Property (TRIPS), they set global standards that still determine who gets affordable medicines and who doesn’t. Today, those rules are even more evident through the announcement of Trump's tariff deals. Countries are rushing to Washington following the 2 April 2025 announcement of U.S. Reciprocal Tariffs seeking bilateral deals to shield their economies. But what...
For years, Africa grappled with a steady rise in mpox cases and recurring outbreaks, yet the disease remained largely overlooked by the global community. It was only when the virus reached Northern countries that mpox began to garner international attention. This long-standing neglect is evident in the sparse data on the disease, the minimal investment in research and development of medical countermeasures, delayed regulatory approvals, and stark inequities in access to these measures. In t...
In our inaugural episode, we explore the recent amendments to the International Health Regulations (IHR) and their implications for developing countries, particularly in light of the upcoming session of the Intergovernmental Negotiating Body (INB) negotiating a Pandemic Instrument. The IHR amendments represent a pivotal step towards recognizing the historical inequalities that have long plagued global health systems. Our guest, K.M. Gopakumar, a seasoned researcher and activist from the...
Comments